Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Andrew E. Petroll's publication output changed over time?
ScholarIQpublication output · 2008–2022
Output grew200% over the shown period — from 1 works in 2008 to 3 in 2022.
1
1
2
1
1
1
1
1
3
200820102012201320162017202020212022
What are the most-cited papers on Andrew E. Petroll?
ScholarIQmost cited works
PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists
Andrew E. Petroll, Jennifer L. Walsh, Jill Owczarzak, Timothy L. McAuliffe, Laura M. Bogart, Jeffrey A. Kelly
AIDS and Behavior. 2016311 CitationsOPEN ACCESS
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review
Benedikt Pleuhs, Katherine Quinn, Jennifer L. Walsh, Andrew E. Petroll, Steven A. John
S14583120. 2020257 CitationsOPEN ACCESS
Physician Awareness of Sexual Orientation and Preventive Health Recommendations to Men Who Have Sex With Men
Andrew E. Petroll, Katie E. Mosack
S170339494. 2010227 CitationsOPEN ACCESS
Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review
Madeline Dang, Ayden I. Scheim, Michelle Teti, Katherine Quinn, Meagan Zarwell, Andrew E. Petroll, Keith J. Horvath, Steven A. John
S14583120. 2022101 CitationsOPEN ACCESS
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer, Laura Salazar, Keith Henry, David M. Asmuth, David A. Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Stephanie Cox, Alexander Kintu, Christoph C Carter, Moupali Das, Jared M. Baeten, Diana M. Brainard, Gary Whitlock, Jason Brunetta, Gitte Kronborg, Christoph D. Spinner, Andrea Antinori, Vanessa Apea, David M. Asmuth, Ann Avery, Paul Benson, Colm Bergin, Mezgebe Berhe, Indira Brar, Cynthia Brinson, Jason Brunetta, Jeffrey H. Burack, Thomas L. Campbell, Michelle Cespedes, Amanda Clarke, Megan Coleman, J Coll, Manuel Crespo Casal, Catherine Creticos, Gordon Crofoot, Frederick Cruickshank, Éric Cua, Eric S. Daar, Joseph de Wet, Edwin DeJesus, Jorge Del Romero Guerrero, William D. Dinges, Susanne Doblecki‐Lewis, Taylor Donovan, Olamide Dosekun, Jason Flamm, Joel E. Gallant, Jan Gerstoft, Richard Gilson, Jay Gladstein, Robert M. Grant, Robert Grossberg, Bernhard Haas, Jason Halperin, William D. Hardy, C. Bradley Hare, Shawn Hassler, Richard L. Hengel, William Henry, Theo Hodge, Sybil Hosek, Chris Hurt, Michelle Iandiorio, Heiko Jessen, Stephen Kegg, Gabriele Knecht, Gitte Kronborg, Ivanka Krznaric, Anthony LaMarca, Carsten Schade Larsen, Olav Larsen, Adriano Lazzarin, Clifford Leen, Christopher Lucasti, Patrick Mallon, Sharon Mannheimer, Martin Markowitz, Claudia Martorell, Kenneth Mayer, Anthony Mills, Jean‐Michel Molina, Sheldon Morris, Karam Mounzer, Nneka Nwokolo, Onyema Ogbuagu, Olayemi Osiyemi, Andrew E. Petroll, Patrick Philibert, John Phoenix, G. Pialoux, Daniel Podzamczer, Frank A. Post, Maria Prins, Moti Ramgopal, Bruce Rashbaum, Iain Reeves
S2531945440. 202191 CitationsOPEN ACCESS
Related on ScholarIQ
Froedtert Hospital
Institution
PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists
Paper
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review
Paper
Physician Awareness of Sexual Orientation and Preventive Health Recommendations to Men Who Have Sex With Men
Paper
Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review
Paper
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Paper